Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Gabapentin | [4] Gabapentin Gabapentin; GABAPENTINA; Gabapentine; NEURONTIN | [1] Gabapentin
Gabapentin
💬 | [5] CACNA2D1 CACNA2D1,CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [5] 6 6, 13, 19, 70, 298 💬 |
| 2 |
Lidocaine
(ACTIVE-PAC with Gabapentin) | [4] Aloe Aloe; Lidocaine; Lignocaine; Xylocaine | [2] Lidocaine
Lidocaine
,Lidocaine hydrochloride monohydrate 💬 | [5] SCN1A SCN1A,SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [13] 6 6, 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 💬 |